13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • CTC prostate

    Acronym: 

    CTC prostate

    ACTRN/NCT /ethics: 

    Ethics: 398.15

    Scientific title: 

    Identification of Biomarkers through analysis of circulating tumour cells in Australian men with prostate cancer

    Summary of trial and patient characteristics

    Cancer Type Prostate
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases Tumour Stream Prostate
    Age Range 18 years and older Cancer Stage All stages
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Prostate
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Prostate
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    Identification of Biomarkers through analysis of circulating tumour cells in Australian men with prostate cancer.

    Lay Summary

    Identification of Biomarkers through analysis of circulating tumour cells in Australian men with prostate cancer

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Chris Karapetis Not Yet Recruiting